Nature of Disclosure: Regulatory intimation regarding board meeting schedule and trading window closure compliance.
Board Meeting Details: The meeting of the Board of Directors is scheduled to be held on Friday, October 30, 2026. The primary agenda includes consideration and approval of the Unaudited Financial Results (Standalone) of the Company for the quarter and half year ended September 30, 2026.
Trading Window Closure: In continuation of the company's letter dated September 28, 2026, the trading window for dealing in the company's shares remains closed from October 1, 2026 until 48 hours after the declaration/announcement of the financial results for the quarter and half year ended September 30, 2026.
Regulatory Compliance: The intimation is made pursuant to Regulation 29(1)(a) read with Regulation 50(1)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Impact: Not quantified in this disclosure. The impact will be determined following board approval of the financial results.